Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
09/17/202011:36AMDow Jones NewsDeveloping Countries Push to Limit Patent Protections for Covid VaccinesNYSE:GSKGSK plc
09/11/202012:50PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/09/20206:45PMBusiness WireFDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Both Asthma & COPD in...NYSE:GSKGSK plc
09/09/202010:58AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/09/20209:00AMPR Newswire (US)Advil Taps Leading Lady and Super Mom Angela Kinsey for the Launch of Major Pain Innovation, Advil Dual ActionNYSE:GSKGSK plc
09/09/20208:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/08/20209:25PMDow Jones NewsDrug-Company CEOs Sign Pledge on Covid-19 Vaccine -- 2nd UpdateNYSE:GSKGSK plc
09/08/202012:45PMPR Newswire (US)GSK Consumer Healthcare Introduces the Biggest Innovation in the U.S. Over-The-Counter Oral Pain Relief Category in 25 Years:...NYSE:GSKGSK plc
09/08/20206:30AMGlobeNewswire Inc.Biopharma Leaders Unite to Stand with ScienceNYSE:GSKGSK plc
09/08/20206:30AMBusiness WireBiopharma Leaders Unite to Stand with ScienceNYSE:GSKGSK plc
09/08/20206:30AMBusiness WireBiopharma Leaders Unite To Stand With ScienceNYSE:GSKGSK plc
09/03/20206:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/03/20202:01AMDow Jones NewsSanofi, GlaxoSmithKline Start Phase 1/2 Trial of Covid-19 Vaccine CandidateNYSE:GSKGSK plc
09/01/202011:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
08/31/20201:00PMPR Newswire (Canada)SK announces first participant vaccinated in Phase 3 Clinical Trials of its 5-in-1, Meningitis ABCWY vaccine candidateNYSE:GSKGSK plc
08/31/20201:00PMPR Newswire (Canada)GSK annonce la vaccination d'un premier participant à l'étude clinique de phase III sur son vaccin expérimental 5-en-1 con...NYSE:GSKGSK plc
08/31/20209:26AMDow Jones NewsVir, GlaxoSmithKline Begin Phase 2/3 Study of Covid-19 TreatmentNYSE:GSKGSK plc
08/31/20208:00AMGlobeNewswire Inc.Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody TreatmentNYSE:GSKGSK plc
08/27/20202:50AMDow Jones NewsGlaxoSmithKline Gets Approval for Myeloma Treatment in EUNYSE:GSKGSK plc
08/10/202012:25PMDow Jones NewsCureVac Sets IPO at 13.3 Million Shares; Sees Pricing at $14-$16 EachNYSE:GSKGSK plc
08/06/20206:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
08/05/20209:08PMBusiness WireFDA Approves GSK’s BLENREP (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple M...NYSE:GSKGSK plc
08/03/20209:15AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
08/03/20207:29AMDow Jones NewsGilead Shows the Dangers of Covid-19 Drug Mania -- Heard on the StreetNYSE:GSKGSK plc
08/03/20207:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
08/03/20202:49AMDow Jones NewsGlaxoSmithKline and Sanofi to Supply EU With 300 Million Covid-19 DosesNYSE:GSKGSK plc
07/31/20203:18PMDow Jones NewsSanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S. -- UpdateNYSE:GSKGSK plc
07/31/202010:58AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/31/202010:03AMDow Jones NewsEuropean Companies Begin Reinstating Guidance After Coronavirus UpheavalNYSE:GSKGSK plc
07/31/20207:29AMDow Jones NewsSanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S.NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK